This reduction may compromise the liver's ability to manage oxidative stress and perform detoxification, potentially contributing to disease progression
Alan has treated me twice, which was a godsend when so many other things I tried failed
Clinical trials and user reports indicate that gastrointestinal disturbances, including burping, are relatively common among individuals taking this medication
It's good to know that it doesn't have ALA (Alpha Lipoic Acid) because some are allergic to it
#BioTech #ArtivaBiotherapeutics #CellTherapy #AutoimmuneDisease #RheumatoidArthritis To view or add a comment, sign in Roche has secured FDA approval for Gazyva/Gazyvaro (obinutuzumab) for the treatment of lupus nephritis
Hanson RL, Imperatore G, Bennett PH, Knowler WC